CLINICAL_TRIALS
trial_result
· 2010-04-12
Clinical Trial Update: Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer [Phase 2]
Summary
A Phase II trial in patients with recurrent non-small cell lung cancer has completed, according to a clinical trial update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED